
Response Oncology, Inc.
Action · US7612323052 (OTC)
Pas de cours
n/a
Profil de l'entreprise pour Response Oncology, Inc. Action
Response Oncology, Inc. does not have significant operations. The company, along its wholly owned and majority owned subsidiaries, operated as a comprehensive cancer management company. As of May 20, 2002, the company has liquidated substantially all of its operating assets and anticipates that the remaining assets would be liquidated and all wind-down activities completed by the end of 2002. Prior to the sale of its assets, it provided: advanced cancer treatment services through outpatient facilities known as IMPACT Centers under the direction of practicing oncologists; owned the assets of and managed the nonmedical aspects of oncology practices; compounded and dispensed pharmaceuticals to certain oncologists for a fixed or cost plus fee; and conducted outcomes research on behalf of pharmaceutical manufacturers. The company was incorporated in 1984 and is based in Memphis, Tennessee.
Données de l'entreprise
Nom Response Oncology, Inc.
Société Response Oncology, Inc.
Marché d'origine
UTC
ISIN US7612323052
Type de titre Action
Secteur Healthcare
Industrie Medical - Care Facilities
PDG Charles E. Sweet
Pays États-Unis d'Amérique
Devise USD
Employés 0,0 T
Date d'introduction en bourse 2000-01-03
Symboles boursiers
| Nom | Symbole |
|---|---|
| Over The Counter | ROIX |
Autres actions
Les investisseurs qui détiennent Response Oncology, Inc. ont également les actions suivantes dans leur portefeuille :
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles.
Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.


